Preparation and distribution of research drug products
Closed Solicitation Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- 75N95024R00003
- Agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Place of performance
- United States
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institute on Drug Abuse (NIDA) is seeking to acquire a wide variety of authentic controlled and uncontrolled drug compounds, dosage forms, and research cigarettes to support drug abuse and addiction research through this solicitation. The contractor will be required to import drug compounds, develop and prepare drug dosage forms, manufacture and analyze research cigarettes, and store and distribute these products upon issuance of task orders. The evaluation criteria includes the technical approach, relevant experience and past performance, and business proposal. The proposal deadline is November 15, 2024 at 1:00 PM Eastern Time.
This is an unrestricted procurement with no set-aside. NIDA anticipates awarding one indefinite delivery, indefinite quantity (IDIQ) contract with a minimum value of $100,000 and a maximum of $19,975,000 over the 5-year period of performance. The place of performance is the United States.
Notice text
The NIDA Drug Supply Program plays a major role in promoting drug abuse and drug addiction research by providing to the drug abuse research community with a wide variety of authentic controlled and uncontrolled drug compounds, some of their dosage forms, and marijuana and nicotine research cigarettes for research. Through this contract NIDA plans to continue to acquire drug compounds, drug dosage forms for the NIDA drug supply inventory, to have capability to import drug compounds from international sources, to develop and prepare drug dosage forms, to have capability to manufacture marijuana and nicotine research cigarettes, to frequently analyze them for purity, and to store and distribute them for research upon NIDA authorization according to DEA regulations. Such dosage forms of controlled and uncontrolled drug compounds include morphine, methadone and naltrexone pellets of various strengths, their placebo counterparts, and various cannabinoid preparations (delta-8- and delta-9- tetrahydrocannabinol, cannabidiol, cannabinol, and cannabichromene) and other compounds of interest to the drug abuse research community.
Upon issuance of Task Orders, the Contractor shall acquire, analyze, store, and ship bulk drugs, other chemical compounds, and drug dosage forms to aid NIDA in promoting drug abuse and drug addiction research.
Files
| File | Type | Posted |
|---|---|---|
| Amendment 02.pdf | ||
| Amendment 01.pdf | ||
| Solicitation_75N95024R00003_F.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Preparation and distribution of research drug products | Award Notice | |
| This notice | Solicitation | |
| Preparation and distribution of research drug products | Pre-Solicitation | |
| Preparation and distribution of research drug products | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Synthesis and Distribution of Drugs of Abuse and Related Compounds | National Institute on Drug Abuse | No set-aside | |
| Synthesis and Distribution of Drugs of Abuse and Related Compounds | National Institute on Drug Abuse | Total Small Business |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity